152 related articles for article (PubMed ID: 30457555)
1. Genome-wide Estrogen Receptor-α activation is sustained, not cyclical.
Holding AN; Cullen AE; Markowetz F
Elife; 2018 Nov; 7():. PubMed ID: 30457555
[TBL] [Abstract][Full Text] [Related]
2. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells.
Ying S; Dünnebier T; Si J; Hamann U
PLoS One; 2013; 8(9):e75695. PubMed ID: 24086615
[TBL] [Abstract][Full Text] [Related]
4. BRCA2 represses the transcriptional activity of pS2 by E2-ERα.
Fukuda M; Tojo Y; Sato A; Saito H; Nakanishi A; Miki Y
Biochem Biophys Res Commun; 2022 Jan; 588():75-82. PubMed ID: 34952473
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.
Stender JD; Kim K; Charn TH; Komm B; Chang KC; Kraus WL; Benner C; Glass CK; Katzenellenbogen BS
Mol Cell Biol; 2010 Aug; 30(16):3943-55. PubMed ID: 20547749
[TBL] [Abstract][Full Text] [Related]
6. Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins.
Sun JM; Spencer VA; Li L; Yu Chen H; Yu J; Davie JR
Exp Cell Res; 2005 Jan; 302(1):96-107. PubMed ID: 15541729
[TBL] [Abstract][Full Text] [Related]
7. Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells.
Simpson NE; Gertz J; Imberg K; Myers RM; Garabedian MJ
Mol Endocrinol; 2012 Jan; 26(1):194-202. PubMed ID: 22074947
[TBL] [Abstract][Full Text] [Related]
8. Non-coding single nucleotide variants affecting estrogen receptor binding and activity.
Bahreini A; Levine K; Santana-Santos L; Benos PV; Wang P; Andersen C; Oesterreich S; Lee AV
Genome Med; 2016 Dec; 8(1):128. PubMed ID: 27964748
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.
Kona FR; Stark K; Bisoski L; Buac D; Cui Q; Dou QP
Breast Cancer Res Treat; 2012 Sep; 135(2):495-503. PubMed ID: 22850893
[TBL] [Abstract][Full Text] [Related]
11. Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes.
Guertin MJ; Zhang X; Coonrod SA; Hager GL
Mol Endocrinol; 2014 Sep; 28(9):1522-33. PubMed ID: 25051172
[TBL] [Abstract][Full Text] [Related]
12. Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.
Du J; Zhou N; Liu H; Jiang F; Wang Y; Hu C; Qi H; Zhong C; Wang X; Li Z
PLoS One; 2012; 7(4):e35957. PubMed ID: 22558281
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
Al-Dhaheri MH; Rowan BG
Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
[TBL] [Abstract][Full Text] [Related]
14. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
[TBL] [Abstract][Full Text] [Related]
15. SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.
Chan HJ; Li H; Liu Z; Yuan YC; Mortimer J; Chen S
Oncotarget; 2015 Sep; 6(28):25815-27. PubMed ID: 26158350
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
17. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 determines estrogen signaling in the mammary gland in vivo.
Casimiro MC; Wang C; Li Z; Di Sante G; Willmart NE; Addya S; Chen L; Liu Y; Lisanti MP; Pestell RG
Mol Endocrinol; 2013 Sep; 27(9):1415-28. PubMed ID: 23864650
[TBL] [Abstract][Full Text] [Related]
19. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
20. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression.
Stoica A; Saceda M; Fakhro A; Joyner M; Martin MB
J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
